Form 4: Addus HomeCare Director Susan T. Weaver Receives Restricted Stock Grant

Addus HomeCare Corp. Director Susan T. Weaver was granted 1,172 restricted shares of common stock, vesting in June 2026, as part of her compensation.

Summary

• Susan T. Weaver, a Director of Addus HomeCare Corp. (ADUS), acquired 1,172 shares of common stock.
• The transaction occurred on June 18, 2025.
• These shares were granted as restricted stock to non-employee directors at a price of $0 per share.
• The granted shares will vest in full on June 18, 2026.
• Following this transaction, Susan T. Weaver beneficially owns 12,295 shares of common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates standard corporate governance and director compensation practices, aligning director interests with shareholders. It's a routine filing, not indicative of major positive or negative news.

Positives

• The grant of restricted stock aligns the interests of Director Susan T. Weaver with those of shareholders, as the value of her compensation is tied to the company's stock performance.
• This is a standard form of non-cash compensation for non-employee directors, indicating continuity in the company's governance structure and compensation practices.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook, beyond the vesting schedule of the granted shares.

Industry Context

The granting of restricted stock to non-employee directors is a common practice across various industries, including healthcare services, to attract and retain qualified board members. This method of compensation helps align the interests of directors with long-term shareholder value creation by tying a portion of their remuneration to the company's stock performance.

Comparison to Industry Standards

• The grant of restricted stock to a director at a $0 price, with a future vesting date, is a standard compensation mechanism for non-employee directors in publicly traded companies.
• This practice is consistent with typical corporate governance and compensation structures observed in the healthcare services sector, similar to how companies like Encompass Health Corporation or LHC Group might compensate their non-executive board members, aiming to foster long-term commitment and alignment with shareholder interests.

Related Party Transactions

• The grant of 1,172 restricted shares to Susan T. Weaver, a Director of Addus HomeCare Corp., constitutes a related party transaction as she is an insider of the company.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially encouraging long-term value creation. It represents a minor dilution if new shares are issued, or a use of treasury shares.
• Employees: No direct impact on general employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Next Steps

• The 1,172 restricted shares granted to Susan T. Weaver are scheduled to vest in full on June 18, 2026.

Key Dates

Recommendation

Keywords

Addus HomeCare Corp, ADUS, SEC Form 4, restricted stock, stock grant, director compensation, insider transaction, equity compensation, Susan T. Weaver